BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4116282)

  • 1. [In-vitro inhibition of thrombocyte aggregation induced by xenogenic serum].
    von Kaulla KN; Gerloff J
    Res Exp Med (Berl); 1972; 158(2):152-64. PubMed ID: 4116282
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of dog serum-induced aggregation of pig platelets.
    Gerloff J; Von Kaulla KN
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):298-303. PubMed ID: 5082302
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucopolysaccharides and platelet aggregation.
    Scharrer I; Breddin K
    Acta Univ Carol Med Monogr; 1972; 53():27-31. PubMed ID: 4133933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A; Citarrella P; Carreca I
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrokinetic phenomena and platelet aggregation. I. Electrokinetic studies.
    Stolz JF; Migne J; Alexandre P; Santonja R; Streiff F; Larcan A
    Acta Univ Carol Med Monogr; 1972; 53():53-7. PubMed ID: 4133935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of thrombocyte adhesion in children (author's transl)].
    Suschke J; Stehr K; Jacobi E; Jurzik ML; Krejci K
    Klin Padiatr; 1973 Jul; 185(4):287-96. PubMed ID: 4542896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic drugs of a non-enzymatic nature (review of the literature)].
    Ivleva AIa; Zolotukhin SI
    Farmakol Toksikol; 1973; 36(3):359-65. PubMed ID: 4132908
    [No Abstract]   [Full Text] [Related]  

  • 8. Aggregation of human blood platelets by immune complexes in the sedimentation pattern test.
    Myllylä G
    Scand J Haematol Suppl; 1973; 19():1-56. PubMed ID: 4127837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an synthetic heparinoid (SP-54) on platelet aggregation.
    Aznar J; Baguena R; Garcia-Conde J; Alberola V
    Rev Esp Fisiol; 1968 Dec; 24(4):155-60. PubMed ID: 4184522
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dose-dependent effect of heparin and SP-54 on Triton-induced lipemia in rats.
    Solyom A; Cseh G; Villànyi K
    Life Sci; 1965 Jul; 4(14):1411-20. PubMed ID: 4158775
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibition of thrombocyte adhesion by bencyclane: experimental and clinical results.
    Martin M; Schäfer G; Martin U; Juraschek H; Knüll W
    Thromb Res; 1974 Jun; 4(6):741-52. PubMed ID: 4844058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of collagen induced aggregation of human thrombocytes using phenyl derivatives of 4-amino-thiopen-3 carbonic acid a new group of synthetic fibrinolytic agents].
    von Kaulla KN; Thilo D
    Klin Wochenschr; 1970 Jun; 48(11):668-73. PubMed ID: 5517514
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural studies of platelet 'activation' and aggregation in normal spleen from different species.
    Elgjo RF; Hovig T
    Scand J Haematol; 1972; 9(6):587-602. PubMed ID: 4644423
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Effects of heparin derived from different tissues on plasma-phospholipids and platelet aggregation.
    Gillett MP; Besterman EM
    Lancet; 1973 Nov; 2(7839):1204-5. PubMed ID: 4127572
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of platelet aggregation. 1. 5,10-Dihydro-3-(phenyl, thienyl, and furyl)thiazolo(3,2-b)(2,4)benzodiazepines and related compounds.
    Elslager EF; McLean JR; Perricone SC; Potoczak D; Veloso H; Worth DF; Wheelock RH
    J Med Chem; 1971 May; 14(5):397-401. PubMed ID: 5117685
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.
    Mikhailidis DP; Barradas MA; Mikhailidis AM; Magnani H; Dandona P
    Br J Clin Pharmacol; 1984 Jan; 17(1):43-8. PubMed ID: 6197984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.